Download hypothyroidism and hyperthyroidism. and more Slides Clinical Medicine in PDF only on Docsity!
Topic:
Hypo &
Hyperthyroidism
Hyperthyroidism
Definition:
Hyperthyroidism is an overactive thyroid gland that produces too much thyroid
hormone.
Who is at risk:
- (^) An overactive thyroid can affect anyone, but it’s about 10 times more
common in women than men, and typically happens between 20 and 40
years of age.
- (^) A recent pregnancy, which raises the risk of developing thyroiditis. Which can
lead to hyperthyroidism.
- (^) A family history of thyroid disease, particularly Graves’ disease.
Primary
Due to thyroid hormone deficiency
Secondary
Due to TSH deficiency 01 02
Tertiary
Due to thyrotropin-releasing hormone deficiency Extra-thyroidal; panel 03 04
Hypothyroidism can be classified as:
Peripheral
What is the main cause of
hypothyroidism?
Hashimoto’s disease, an autoimmune disorder,
is the most common cause of hypothyroidism.
With this disease, your immune system attacks
the thyroid. The thyroid becomes inflamed
and can’t make enough thyroid hormones.
How is hypothyroidism transmitted?
In some of these cases, an affected
person inherits the mutation from one
affected parent. Other cases result from
new (de novo ) mutations in the gene
that occur during the formation of
reproductive cells (eggs or sperm) or in
early embryonic development
Causes of Hyperthyroidism
Primary Secondary
- (^) Autoimmune (^) Graves’ disease (^) Ashimoto’s (Hashitoxicosis - rare)
- (^) Toxic multinodular
- (^) Goiter toxic adenoma
- (^) Exogenous thyroid hormone intake
- (^) Postpartum thyroiditis
- (^) Neoplastic (usually metastatic thyroid cancer - very rare)
- (^) Drug-induced (amiodarone) TSH-producing pituitary adenoma
- (^) Gestational hyperthyroidism (seen with hyperemesis gravidarum)
- (^) Trophoblastic disease
Others
Investigations/Diagnostic
Tests
- (^) TSH is the principal test for evaluating thyroid function.
- (^) free T3 (fT3) and free T4 (fT4) are not necessary when screening for hypothyroidism (^) may measure in suspected hyperthyroidism to confirm the diagnosis of thyrotoxicosis (elevated fT3 and normal fT4) (^) may measure to rule out TSH-producing pituitary adenoma (elevated TSH, fT3, fT4)
- (^) a thyroid ultrasound should be done if the physical exam suggests nodularity
- A thyroid uptake scan should be done to differentiate the causes of a hyperthyroid state
Diagnosis Algorithm
roid TSHATY <0.3 m U / L Hyperthyroidism suspected
- 3 - 5.5 m U / L Euthyroid >5.6 m U / L Hypothyroidism Suspected Ft 4 Elevated Normal Ft 3 Hyperthyroidism^ Elevated^ Normal Confirmed Review Etiology and Rx Monitor fT Review clinical diagnosis repeat TSH at 6 to 12 months if indicated. fT 4 Normal Low Hypothyroidism Confirmed Treatment – thyroid replacement therapy Monitor TSH Wait 6-8 weeks after start of treatment or Change in dosage before re-testing TSH Consider Dose increase Consider dose reduction TSH Elevated TSH Normal Appropriate dose established. Test TSH annually TSH Suppressed Review clinical diagnosis
Hypothyroidism Treatment
For treatment steps are as follows:
1. First understand the cause of disease because Hypothyroidism is a disorder of
diverse causes.
2. Medical History:
- (^) A comprehensive medical history can uncover symptoms
- (^) that will help establish the diagnosis and confirm by history and to document pretreatment thyroid function abnormalities and Patients should be asked about symptoms.
3. Physical Examination:
- (^) Findings from the physical examination that may indicate hypothyroidism include goiter or bradycardia, edema.
4. Laboratory Evaluation.
- (^) Serum TSH measurement should be performed
THEN, Give: Treatment plan
- (^) Levothyroxine sodium is the treatment of choice for the routine management of
hypothyroidism.
- (^) Levothyroxine, also known as L-thyroxine, is a synthetic form of the thyroid
hormone thyroxine. It is used to treat thyroid hormone deficiency.
- (^) Dosage: Therapy is usually initiated in patients under the age of 50 years with
full replacement.
- (^) Adults with hypothyroidism require approximately 1.7 μg/kg of body weight per
day for full replacement.
- (^) Children may require higher doses (up to 4 μg/kg of body weight per day).
- (^) Older patient s may need less than 1 μg/kg per day.
Special Considerations:
Elderly patients:
Symptoms should be monitored and TSH levels.
Pregnancy:
TSH Requirement increases which leads to an increase in Levothyroxine concentration.
In Subclinical Hypothyroidism:
As many as 15% of patients older than 65 years, as well as many other adults, have
hypothyroid symptoms called subclinical hypothyroidism, and usually feel better if
treated with levothyroxine.
In MyxedemaComa:
Coma caused by myxedema is a rare, life-threatening
state associated with altered sensorium caused by hypothyroidism.
Therapy of myxedema coma
Includes intravenous administration of levothyroxine and/or liothyronine sodium at a
dose of 500-800 mcg.
Use of Other Thyroid Hormone Preparations
● Liothyronine is a manufactured form of the
thyroid hormone triiodothyronine. It is most
commonly used to treat hypothyroidism and
myxedema coma.
● Dosage:
Adults—At first, 25 micrograms (mcg) once a
day.
Children at 5 micrograms once a day
Treatment plan for hyperthyroidism
These include
1. Antithyroid Drugs. ● (^) The ATDs, include Methimazole Mechanism of action: ● (^) Interfere with the oxidation of the iodide ion and iodotyrosyl groups. Eventually, thyroglobulin gets depleted, and circulating thyroid hormone levels decrease. Propylthiouracil (preferred for pregnant) Mechanism of action: ● Acts by inhibiting the enzyme thyroid peroxidase, which usually converts iodide to an iodine molecule and incorporates the iodine molecule into amino acid tyrosine and thyroid hormone biosynthesis. ● (^) Dosage: ● (^) Initial daily doses of methimazole generally range from 10 to 40 mg, and for propylthiouracil, 100 to 600 mg for 6 weeks to 2 years orally.
Hyperthyroidism and pregnancy:
● The goal of treatment during pregnancy is to maintain
euthyroidism, using the smallest doses of ATDs possible.
Hyperthyroid pregnant patients should be seen at 4- to 6-week
intervals.
Surgery is felt to be necessary because of the inability to
adequately control hyperthyroidism with ATDs,